Innovative Technology CoaguSense’s proprietary coagulation monitoring system employs direct clot detection technology, offering highly accurate and precise results, which can appeal to healthcare providers seeking reliable point-of-care diagnostics.

Growth Potential With a revenue range of 1 to 10 million and recent acquisition by i-SENS Inc, there is significant opportunity to expand market reach within the diagnostics and medical device sectors, especially targeting clinics and hospitals.

Market Differentiation As the first to market with their direct clot detection system for PT/INR testing, CoaguSense holds a competitive edge that can be leveraged to attract new clients interested in innovative anticoagulation management solutions.

Strategic Acquisition Being part of i-SENS Inc, a global leader in point-of-care diagnostics, provides access to broader distribution channels and technological synergies that can accelerate sales efforts and expand customer base.

Customer Focus Targeting healthcare institutions that require accurate and rapid coagulation testing presents an opportunity to address unmet needs in anticoagulation monitoring, particularly with the rising demand for at-home and mobile health solutions.